Previous studies have determined that EGFR activation and mitogenic signaling cascades are involved in androgen-independent prostate cancer tumor cell survival and proliferation, and are important factors in the development of CRPC following androgen ablation20, 21. This evidence concerns the gene EGFR and neoplasm.